Medical Systems & Design, Ltd. a two year field study on the effectiveness of
their "natural nutritional compound", Cerasomal-cis-9-cetylmyristoleate (CMO), .
The main thrust of this battery of tests was primarily focused on arthritis.
The study involved
888 female subjects ranging in age from 28 to 82, and 926 male subjects ranging in age
from 29 - 74. All races and many ethnic backgrounds were represented. Age, gender, race,
and ethnological background appeared to be irrelevant to patient response in this study.
However, younger subjects seemed to respond earlier to the regimen program.
CMO was administered
orally in the form of three capsules each morning and evening until the 96 capsules were
consumed for 16 days. The subjects were examined on the eighth and sixteenth day for
evaluation regarding pain, swelling and inflammation.
were found after testing the 1,814 subjects. The results showed that over 87% of the
subjects had greater than 50% recovery and over 65% of those showed from 75% - 100%
recovery following a sixteen day regimen. All types of arthritis were positively affected
improvement in all subjects except those who had suffered liver damage or those with
digestive problems or disorders. Otherwise, every patient benefited.